🇺🇸 RCUS — Arcus Biosciences, Inc.
Salud Compra fuertePrecio actual
19,31 USD
Máx. histórico
48,47
1807 días
Caída desde máximo
-60,16%
Rango 52 semanas
17,43 – 31,74
Variación hoy
+2,12%
Cierre anterior
18,91
Rango de hoy
18,60 – 19,61
Volumen hoy
2.076.185
Peor caída histórica
-85,83%
23/11/2021 → 04/04/2025
Aún sin recuperar
Volatilidad anualizada ⓘ
75,61%
- Nombre completo
- Arcus Biosciences, Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 601
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 41,00 USD (puede no estar actualizado)
- Primera cotización
- 15/03/2018
- Precio actualizado
- hace 13 horas
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers; and Zimberelimab, an anti-PD-1 antibody. It also develops Quemliclustat, a small molecule inhibitor that targets the CD73 enzyme in the ATP-adenosine pathway, which is in phase 3 and phase 1/1b clinical trial for lung and pancreatic cancer. In addition, the company develops AB598, a CD39 antibody, which is in phase 1/1b clinical study for gastrointestinal cancer and AB801, an AXL inhibitor, which is in Phase 1b clinical trial for lung cancer. It has clinical collaboration with AstraZeneca for the Phase 3 PACIFIC-8 trial evaluating domvanalimab and durvalumab in Stage 3 NSCLC and for a Phase 1/1b study evaluating casdatifan and volrustomig in IO-naive patients with ccRCC; BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases; and Bristol-Myers Squibb Company to develop a novel treatment regimen that delivers tumor control in kidney cancer. Arcus Biosciences, Inc. was incorporated in 2015 and is based in Hayward, California.
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/12/2019 | 8,28 | 8,45 | 7,91 | 8,06 | -2,54% | 6,52% | 133.000 |
| 29/11/2019 | 8,35 | 8,57 | 8,15 | 8,27 | -1,43% | 5,03% | 70.000 |
| 27/11/2019 | 8,74 | 8,80 | 8,34 | 8,39 | -3,34% | 5,26% | 77.700 |
| 26/11/2019 | 9,54 | 9,54 | 8,63 | 8,68 | -8,82% | 9,54% | 114.900 |
| 25/11/2019 | 8,87 | 9,56 | 8,79 | 9,52 | +8,43% | 8,68% | 259.100 |
| 22/11/2019 | 8,06 | 8,92 | 8,05 | 8,78 | +10,16% | 10,79% | 244.500 |
| 21/11/2019 | 7,82 | 8,00 | 7,65 | 7,97 | +2,44% | 4,54% | 82.300 |
| 20/11/2019 | 7,52 | 7,97 | 7,52 | 7,78 | +2,77% | 5,98% | 129.500 |
| 19/11/2019 | 7,42 | 7,77 | 7,37 | 7,57 | +3,27% | 5,39% | 54.100 |
| 18/11/2019 | 7,64 | 7,69 | 7,19 | 7,33 | -4,18% | 6,54% | 136.400 |
| 15/11/2019 | 8,06 | 8,06 | 7,55 | 7,65 | -4,02% | 6,33% | 87.400 |
| 14/11/2019 | 8,07 | 8,07 | 7,87 | 7,97 | -0,25% | 2,54% | 55.200 |
| 13/11/2019 | 7,95 | 8,03 | 7,73 | 7,99 | -0,62% | 3,77% | 89.300 |
| 12/11/2019 | 8,15 | 8,39 | 7,87 | 8,04 | +5,37% | 6,43% | 155.100 |
| 11/11/2019 | 7,50 | 7,72 | 7,33 | 7,63 | +1,19% | 5,13% | 93.800 |
| 08/11/2019 | 7,47 | 7,66 | 7,31 | 7,54 | -0,79% | 4,62% | 120.700 |
| 07/11/2019 | 8,13 | 8,21 | 7,49 | 7,60 | -7,09% | 8,86% | 168.700 |
| 06/11/2019 | 8,03 | 8,44 | 7,82 | 8,18 | -2,15% | 7,72% | 167.900 |
| 05/11/2019 | 8,10 | 8,42 | 7,96 | 8,36 | +3,85% | 5,68% | 139.100 |
| 04/11/2019 | 8,17 | 8,25 | 7,72 | 8,05 | -1,23% | 6,47% | 131.300 |
| 01/11/2019 | 7,93 | 8,34 | 7,87 | 8,15 | +3,82% | 5,93% | 104.400 |
| 31/10/2019 | 7,50 | 7,90 | 7,35 | 7,85 | +4,53% | 7,33% | 164.700 |
| 30/10/2019 | 7,61 | 7,67 | 7,39 | 7,51 | -1,57% | 3,68% | 163.200 |
| 29/10/2019 | 7,86 | 7,98 | 7,57 | 7,63 | -2,93% | 5,22% | 135.100 |
| 28/10/2019 | 8,15 | 8,15 | 7,78 | 7,86 | -3,20% | 4,54% | 142.800 |
| 25/10/2019 | 7,88 | 8,24 | 7,85 | 8,12 | +3,05% | 4,95% | 137.200 |
| 24/10/2019 | 8,53 | 8,73 | 7,81 | 7,88 | -7,84% | 10,79% | 249.600 |
| 23/10/2019 | 8,95 | 9,00 | 8,50 | 8,55 | -3,17% | 5,59% | 186.000 |
| 22/10/2019 | 8,51 | 8,91 | 8,43 | 8,83 | +4,13% | 5,64% | 571.500 |
| 21/10/2019 | 8,58 | 8,72 | 8,25 | 8,48 | +0,47% | 5,48% | 933.100 |